Progressing From Metformin to Sulfonylureas or Meglitinides

Workplace Health Saf. 2016 Sep;64(9):433-9. doi: 10.1177/2165079916644263.

Abstract

The article provides an overview of sulfonylureas and meglitinides as second-line agents for treating type 2 diabetes mellitus (T2DM). Implications for occupational health clinicians who work with these individuals when they take either of these medications to achieve target glycemic indices are emphasized.

Keywords: meglitinides; metformin; sulfonylureas; type 2 diabetes mellitus.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Benzamides / administration & dosage*
  • Benzamides / adverse effects
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Glycemic Index
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / adverse effects
  • Metformin / administration & dosage*
  • Metformin / adverse effects
  • Occupational Health
  • Occupational Health Nursing / methods*
  • Sulfonylurea Compounds / administration & dosage*
  • Sulfonylurea Compounds / adverse effects

Substances

  • Benzamides
  • Hypoglycemic Agents
  • Sulfonylurea Compounds
  • meglitinide
  • Metformin